We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
-2.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$135M
AUM Growth
+$5.78M
Cap. Flow
-$3.34M
Cap. Flow %
-2.47%
Top 10 Hldgs %
44.42%
Holding
86
New
6
Increased
26
Reduced
27
Closed
3

Sector Composition

Rank Sector Weight
1 Energy 23.2%
2 Miscellaneous 22.34%
3 Financials 11.53%
4 Consumer Staples 10.62%
5 Healthcare 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
1
Mastercard
MA
$521B
$10.4M 7.71%
154,950
-90
-0.1% -$5.65K
GLD icon
2
SPDR Gold Trust
GLD
$149B
$7.96M 5.89%
62,137
+11,657
+23% +$1.5M
MKC icon
3
McCormick & Company Non-Voting
MKC
$14.9B
$7.19M 5.31%
222,220
-100
-0% -$3.51K
WPZ
4
DELISTED
Williams Partners L.P.
WPZ
$5.7M 4.21%
125,126
+662
+0.5% +$29.3K
MON
5
DELISTED
Monsanto Co
MON
$5.51M 4.08%
52,842
+133
+0.3% +$13.4K
ENB icon
6
Enbridge
ENB
$110B
$4.97M 3.67%
118,984
+833
+0.7% +$35.5K
TRP icon
7
TC Energy
TRP
$64.4B
$4.93M 3.64%
112,226
+833
+0.7% +$37.1K
V icon
8
Visa
V
$712B
$4.64M 3.43%
97,052
+428
+0.4% +$19.8K
LNG icon
9
Cheniere Energy
LNG
$58.3B
$4.6M 3.4%
134,703
+675
+0.5% +$20K
NVS icon
10
Novartis
NVS
$292B
$4.17M 3.08%
60,675
-707
-1% -$46.8K
META icon
11
Meta Platforms (Facebook)
META
$1.47T
$3.77M 2.79%
75,138
+948
+1% +$35.3K
ABV
12
DELISTED
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
$3.47M 2.57%
90,518
+470
+0.5% +$17.2K
UGP icon
13
Ultrapar
UGP
$6.87B
$3.4M 2.51%
276,260
-4,646
-2% -$54.9K
THD icon
14
iShares MSCI Thailand ETF
THD
$351M
$3.26M 2.41%
43,770
-103
-0.2% -$7.82K
AGN
15
DELISTED
Allergan Inc
AGN
$3.21M 2.37%
35,497
-1,062
-3% -$95.3K
IRL
16
DELISTED
NEW IRELAND FUND INC
IRL
$2.77M 2.05%
235,492
+540
+0.2% +$6.13K
AMLP icon
17
Alerian MLP ETF
AMLP
$13.4B
$2.66M 1.97%
30,281
+308
+1% +$27.2K
UPS icon
18
United Parcel Service
UPS
$89.6B
$2.62M 1.94%
28,721
-115
-0.4% -$10.1K
LLY icon
19
Eli Lilly
LLY
$1.05T
$2.6M 1.92%
51,681
-193
-0.4% -$10.1K
ACN icon
20
Accenture
ACN
$116B
$2.58M 1.91%
35,097
-1,094
-3% -$81K
IBB icon
21
iShares Biotechnology ETF
IBB
$10.5B
$2.37M 1.75%
33,897
-1,248
-4% -$81.8K
NVO
22
Novo Nordisk
NVO
$202B
$2.28M 1.68%
134,480
-3,710
-3% -$62.4K
CLR
23
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.2M 1.63%
41,056
+1,330
+3% +$63.7K
MOS icon
24
The Mosaic Company
MOS
$7.5B
$2.15M 1.59%
49,951
-559
-1% -$26K
MMM icon
25
3M
MMM
$89.9B
$2M 1.48%
20,071
-167
-0.8% -$16.2K

Similar funds

Dunvegan Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Dunvegan Associates held 86 positions worth $135M, up 4.5% from $130M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Dunvegan Associates's Q3 2013 filing shows 6 new, 26 increased, 27 reduced and 3 closed positions. Its largest new stake was VanEck Vectors Unconventional Oil & Gas ETF: 960 shares worth $273K. The largest sale was Deere & Co, an estimated $4.52M.

By sector, the portfolio is most concentrated in Energy at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Financials.

  • Dunvegan Associates's largest Q3 2013 buy was VanEck Vectors Unconventional Oil & Gas ETF: 960 shares worth $273K.
  • Dunvegan Associates added most to SPDR Gold Trust in Q3 2013, an estimated $1.5M increase.
  • Dunvegan Associates's biggest Q3 2013 reduction was Deere & Co, cutting an estimated $4.52M.
  • Dunvegan Associates fully exited KODIAK OIL & GAS CORP in Q3 2013, selling an estimated $470K.
  • Dunvegan Associates's ten largest holdings make up 44% of its $135M portfolio in Q3 2013.
  • Dunvegan Associates opened 6 new positions and closed 3 in Q3 2013.
  • Dunvegan Associates's portfolio value rose 4.5% quarter-over-quarter to $135M.

Based on Dunvegan Associates's 13F filing for Q3 2013, filed 13 Nov 2013.